Trial of Cholinergic Agonist in Adults with ADHD
A novel cholinergic activating agent, ABT-418, was used to treat 29 adults with ADHD, in a double-blind, placebo-controlled, randomized, crossover trial at the Pediatric Psychopharmacology Clinic, Massachusetts General Hospital, Boston.
Saved in:
Main Author: | J Gordon Millichap (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
1999-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dopamine Agonist in Treatment of ADHD with Restless Legs Syndrome and ODD
by: J Gordon Millichap
Published: (2005) -
Childhood ADHD and Adult Criminality
by: J Gordon Millichap
Published: (1997) -
Trial of Dexmethylphenidate (Focalin) ER in ADHD
by: J Gordon Millichap
Published: (2006) -
Atomoxetine Open-Label Trial in ADHD
by: J Gordon Millichap
Published: (2002) -
Service Needs of Young Adults with ADHD
by: J Gordon Millichap
Published: (2010)